Vertex Pharmaceuticals Incorporated (FRA:VX1)
381.05
-1.40 (-0.37%)
Last updated: Jun 26, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €97.33 billion as of June 27, 2025. Its market cap has decreased by -16.15% in one year.
Market Cap
97.33B
Enterprise Value
89.03B
Revenue
10.27B
Ranking
n/a
PE Ratio
n/a
Stock Price
€381.05
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 97.33B, an increase of 131,635.79%. That is a compound annual growth rate of 23.57%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SAP SE | 294.56B |
Siemens Aktiengesellschaft | 166.43B |
Deutsche Telekom AG | 149.86B |
Allianz SE | 130.20B |
Rheinmetall AG | 79.15B |
Siemens Energy AG | 73.01B |
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.60B |
Siemens Healthineers AG | 52.36B |